​
​

Tango Therapeutics Ownership | Who Owns Tango Therapeutics?

OverviewForecastRevenueFinancialsChart

Tango Therapeutics Ownership Summary

Tango Therapeutics is owned by 93.51% institutional investors, 12.84% insiders. Trv gp iv is the largest institutional shareholder, holding 17.75% of TNGX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.05% of its assets in Tango Therapeutics shares.

TNGX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTango Therapeutics93.51%12.84%-6.35%
SectorHealthcare Stocks 46.62%8.13%45.25%
IndustryBiotech Stocks 44.91%7.98%47.11%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Trv gp iv19.20M17.75%$164.75M
Ecor1 capital13.33M12.32%$114.38M
Fmr9.41M8.70%$80.73M
Boxer capital8.20M7.58%$70.34M
Nextech invest5.53M5.12%$47.48M
Southpoint capital advisors lp5.28M4.88%$45.27M
T. rowe price investment management4.76M4.40%$40.81M
Blackrock3.99M3.69%$34.22M
Vanguard group3.29M3.05%$28.27M
Bain capital life sciences investors2.89M2.67%$24.82M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Trv gp iv19.20M81.48%$164.75M
Mass general brigham354.19K14.79%$3.04M
Nextech invest5.53M7.99%$47.48M
Boxer capital8.20M3.70%$70.34M
Ecor1 capital13.33M3.50%$114.38M
Braslyn26.96K2.77%$231.32K
Bain capital life sciences investors2.89M2.72%$24.82M
Superstring capital management lp115.57K1.25%$991.60K
Samsara biocapital630.00K1.13%$5.41M
Southpoint capital advisors lp5.28M1.13%$45.27M

Top Buyers

HolderShares% AssetsChange
T. rowe price investment management4.76M0.03%434.43K
Artal group2.52M0.55%325.00K
Balyasny asset management277.01K0.00%277.01K
Vanguard group3.29M0.00%213.69K
Congress asset management co /ma211.17K0.01%211.17K

Top Sellers

HolderShares% AssetsChange
State street1.83M0.00%-1.04M
Point72 asset management---447.11K
Woodline partners lp---348.09K
Soleus capital management1.05M0.79%-300.25K
Ensign peak advisors271.82K0.00%-234.56K

New Positions

HolderShares% AssetsChangeValue
Balyasny asset management277.01K0.00%277.01K$2.38M
Congress asset management co /ma211.17K0.01%211.17K$1.81M
Superstring capital management lp115.57K1.25%115.57K$991.60K
First trust advisors lp49.75K0.00%49.75K$426.88K
Mitsubishi ufj kokusai asset management28.38K0.00%28.38K$243.50K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-12.00
Pacer advisors-415.00
Lazard asset management-2.35K
Metropolitan life insurance co/ny-2.48K
Point72 (difc)-6.28K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241224.27%101,468,8152.91%931.13%56-359.38%
Jun 30, 2024117-7.14%98,597,0350.20%911.10%56-3.45%32-15.79%
Mar 31, 20241265.88%98,397,2575.09%900.98%58-22.67%3872.73%
Dec 31, 202311919.00%93,633,4335.42%961.15%7536.36%22-15.38%
Sep 30, 202310012.36%88,816,12230.00%911.53%5566.67%26-16.13%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.20M2.05%176.00K
Fidelity Growth Compy Commingled Pl S1.70M1.59%8.94K
Fidelity Growth Compy Commingled Pl O1.69M1.58%-
T. Rowe Price Small-Cap Value1.29M1.20%-39.69K
Fidelity Small Cap Growth1.25M1.17%-3.28K
iShares Russell 2000 ETF1.23M1.14%-2.76K
T. Rowe Price Small-Cap Stock1.19M1.11%199.50K
T. Rowe Price US Small-Cap Core Equity1.19M1.11%277.63K
SPDR® S&P Biotech ETF1.14M1.06%12.57K
Fidelity Growth Company Fund989.89K0.92%-2.10K

Recent Insider Transactions

DateNameRoleActivityValue
Nov 14, 2024Rothenberg Mace-Buy$36.20K
Nov 18, 2024Rothenberg Mace-Buy$37.80K
Nov 07, 2024EcoR1 Capital, LLC-Sell$3.33M
Nov 06, 2024EcoR1 Capital, LLC-Sell$4.90M
Nov 07, 2024EcoR1 Capital, LLC-Sell$205.11K

Insider Transactions Trends

DateBuySell
2024 Q427
2024 Q3-18
2024 Q2-7
2024 Q1-9
2023 Q443

TNGX Ownership FAQ

Who Owns Tango Therapeutics?

Tango Therapeutics shareholders are primarily institutional investors at 93.51%, followed by 12.84% insiders and -6.35% retail investors. The average institutional ownership in Tango Therapeutics's industry, Biotech Stocks , is 44.91%, which Tango Therapeutics exceeds.

Who owns the most shares of Tango Therapeutics?

Tango Therapeutics’s largest shareholders are Trv gp iv (19.2M shares, 17.75%), Ecor1 capital (13.33M shares, 12.32%), and Fmr (9.41M shares, 8.70%). Together, they hold 38.77% of Tango Therapeutics’s total shares outstanding.

Does Blackrock own Tango Therapeutics?

Yes, BlackRock owns 3.69% of Tango Therapeutics, totaling 3.99M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 34.22M$. In the last quarter, BlackRock increased its holdings by 126.49K shares, a 3.28% change.

Who is Tango Therapeutics’s biggest shareholder by percentage of total assets invested?

Trv gp iv is Tango Therapeutics’s biggest shareholder by percentage of total assets invested, with 81.48% of its assets in 19.2M Tango Therapeutics shares, valued at 164.75M$.

Who is the top mutual fund holder of Tango Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Tango Therapeutics shares, with 2.05% of its total shares outstanding invested in 2.2M Tango Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools